Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026)

Longeveron's (LGVN) quarterly Asset Utilization Ratio came in at 0.08 in Q1 2026, down 19.41% year-on-year from 0.1 in Q1 2025, and down 16.8% quarter-over-quarter from 0.09 in Q4 2025.

Longeveron (LGVN) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Longeveron's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.08 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 19.41% year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a 19.41% decrease from a year earlier, with the FY2025 full-year figure at 0.07, down 47.33% from the prior year.
  • Asset Utilization Ratio retreated to 0.08 in Q1 2026 per LGVN's latest filing, from 0.09 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.11 in Q2 2025 and bottomed at 0.04 in Q2 2023.
  • The 4-year median for Asset Utilization Ratio is 0.08 (2024), against an average of 0.08.
  • Across the five-year window, Asset Utilization Ratio jumped 129.22% in 2024 and dropped 19.41% in 2026, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.06 in 2023, then surged by 44.17% to 0.09 in 2024, then advanced by 7.69% to 0.09 in 2025, then fell by 16.8% to 0.08 in 2026.
  • Per Business Quant, the three latest LGVN Asset Utilization Ratio figures stand at 0.08 (Q1 2026), 0.09 (Q4 2025), and 0.09 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 0.08

Historic Data

Download Data
DateValue
Mar 31, 2026 0.08
Dec 31, 2025 0.09
Sep 30, 2025 0.09
Jun 30, 2025 0.11
Mar 31, 2025 0.10
Dec 31, 2024 0.09
Sep 30, 2024 0.08
Jun 30, 2024 0.08
Mar 31, 2024 0.09
Dec 31, 2023 0.06
Sep 30, 2023 0.05
Jun 30, 2023 0.04
Mar 31, 2023 0.04